ANGO
AngioDynamics, Inc.
Nasdaq · usd
AngioDynamics, Inc. (ANGO) trades at $11.99 (-2.91%) as of 7:30:01 PM EDT on Oct 30, 2026, -20.70% over the past month. Market cap is $504.23M, with 1.5 days to cover in short interest.
Stock performance
How AngioDynamics, Inc. (ANGO) stock has performed from one day to one year, with its 52-week range.
- 1D
- -2.91%
- 1W
- -3.03%
- 1M
- -20.70%
- YTD
- -6.62%
- 1Y
- +1.35%
- 52-wk range
- $9.39 – $16.29
Key statistics
Today's trading snapshot for ANGO: day range, open, previous close, volume and market cap.
- Day range
- $11.89 – $12.34
- Open
- $12.32
- Prev close
- $12.35
- Volume
- 475.83K
- Market cap
- $504.23M
- Shares out
- 42.05M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for AngioDynamics, Inc.: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 1.55
- P/B
- 3.08
- P/FCF
- —
- ROE
- -20.1%
- ROA
- -13.6%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Oct 30, 2026
8-K filings
Material corporate events AngioDynamics, Inc. has disclosed to the SEC on Form 8-K.
- Ceo appointmentOct 8, 2026
On October 2, 2026, the Board of Directors of the Company appointed Eric Honroth to serve as President and Chief Executive Officer of the Company, effective as of November 2, 2026.
- Investor presentationOct 8, 2026
Presentation slides discussing AngioDynamics and its fiscal first quarter ended August 31, 2026 are furnished herewith as Exhibit 99.2.
- Investor presentationJul 14, 2026
Presentation slides discussing AngioDynamics and its fiscal fourth quarter and full year ended May 31, 2026 are furnished herewith as Exhibit 99.2.
- Material litigationApr 23, 2026
On April 23, 2026, AngioDynamics, Inc. filed a complaint commencing a patent infringement lawsuit in the United States District Court for the District of Delaware against Endovascular Engineering, Inc. The complaint alleges that E2's Hēlo Thrombectomy System unlawfully incorporates several features protected by registered patents held by the Company, including relating to the Company's proprietary self-expanding funnel technology and related features that improve the removal of thrombi and emboli from the body. The complaint seeks damages and equitable relief.
- Investor presentationApr 2, 2026
Presentation slides discussing AngioDynamics and its fiscal third quarter ended February 28, 2026 are furnished herewith as Exhibit 99.2.
ANGO short interest
How heavily ANGO is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.5
- Short interest
- 1.92M
- Avg volume
- 1.31M
As of · reported to FINRA twice monthly.
ANGO news
The latest news and headlines about AngioDynamics, Inc. (ANGO).
- ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/YneutralZacks Investment Research· Oct 9, 2026
- AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue EstimatesneutralZacks Investment Research· Oct 8, 2026
- Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036positiveGlobeNewswire Inc.· Jan 16, 2026
- Why AngioDynamics Stock Is Sinking TodaynegativeThe Motley Fool· Jan 6, 2026
- Why Did AngioDynamics Stock Pop Today?neutralThe Motley Fool· Oct 2, 2025
Frequently asked questions
What is the AngioDynamics, Inc. (ANGO) stock price today?
AngioDynamics, Inc. (ANGO) is trading at $11.99 (-2.91% on the day) as of 7:30:01 PM EDT on Oct 30, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is AngioDynamics, Inc.?
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients…
What is the short interest in ANGO?
As of Oct 15, 2026, ANGO has 1.92M shares short and 1.5 days to cover.
What exchange is ANGO listed on?
AngioDynamics, Inc. (ANGO) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Build with AI
Build an analysis of ANGO with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ANGO analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.